LR-172
LR-172
LR-172 is a synthetic compound that has been studied for its potential applications in medical research, particularly in the field of neuropharmacology. It is known for its role as a selective agonist for certain subtypes of receptors in the central nervous system.
Chemical Structure and Properties[edit | edit source]
LR-172 is classified as a small molecule with a complex chemical structure that allows it to interact specifically with its target receptors. The molecular formula of LR-172 is C21H23N3O2, and it has a molecular weight of 349.43 g/mol. The compound is characterized by its high affinity for the 5-HT2A receptor, a subtype of the serotonin receptor family.
Mechanism of Action[edit | edit source]
LR-172 functions primarily as a selective agonist for the 5-HT2A receptor. This receptor is a G protein-coupled receptor (GPCR) that plays a crucial role in modulating neurotransmission in the brain. By binding to the 5-HT2A receptor, LR-172 can influence various physiological processes, including mood regulation, perception, and cognition.
Pharmacological Effects[edit | edit source]
The activation of 5-HT2A receptors by LR-172 has been shown to produce a range of effects in preclinical studies. These effects include alterations in sensory perception, changes in mood, and potential therapeutic benefits for certain psychiatric disorders. Research is ongoing to determine the full spectrum of pharmacological effects and the potential clinical applications of LR-172.
Research and Development[edit | edit source]
LR-172 is currently under investigation in various research settings to explore its potential as a therapeutic agent. Studies are focusing on its efficacy and safety profile in the treatment of conditions such as depression, anxiety, and schizophrenia. The compound's ability to modulate serotonin pathways makes it a promising candidate for further development.
Safety and Toxicology[edit | edit source]
Preliminary studies on the safety and toxicology of LR-172 suggest that it has a favorable safety profile at therapeutic doses. However, comprehensive toxicological assessments are necessary to fully understand the potential risks associated with its use. Researchers are conducting long-term studies to evaluate the compound's safety in clinical settings.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
